£44.42

It has never been this cheap. We have no record of a lower price.

£44 today · cheaper than every other day in the last 3 months

Springer Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days · 64 data points (no recent data)

Historical
Generating forecast…
£83.41 £40.52 £49.88 £59.24 £68.59 £77.95 £87.31 25 July 2026 09 August 2026 25 August 2026 10 September 2026 26 September 2026
View at Amazon ↗

Price data last checked 27 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 64 days • 3 price levels

Days at Price
Current Price
12 days · current 7 days 45 days 0 11 23 34 45 £44 £82 £83 Days at Price

Price Analysis

Most common price: £83 (45 days, 70.3%)

Price range: £44 - £83

Price levels: 3 different prices over 64 days

Description

Interferon alpha-2 is a genetically engineered, highly purified pharmaceutical agent that has undergone extensive phase I and phase II clinical study in more than 1000 patients. The material has biological activity by intravenous, intramus cular and subcutaneous routes. Clinical toxicity principally involves the 'influen za like' syndrome previously seen with native interferons. Other important toxi cities include anorexia, hepatitis, confusion and myelosuppression. Tolerable doses in multiple schedules and routes of administration have been determined. Phase II clinical trials with multiple routes and schedules of administration have been performed. Significant clinical activity has been found in non Hodgkin's lymphomas (both low grade and high grade), refractory and relapsing multiple myeloma, hairy cell leukemia, Kaposi's sarcoma, with suggestions of activity in Hodgkin's disease, renal cell carcinoma, and melanoma. The studies performed to date have for the most part involved small numbers of heavily pre-treated patients. Large-scale clinical trials in some of these disea ses are now warranted in populations of patients with as little bulk disease and prior treatment as is feasible for each tumour type. This is particularly the case in . Hodgkin's disease and subcategories of the non-Hodgkin's lymphomas. Alterna tely, interferon alpha-2 might be used to maintain remissions induced by other modalities (i. e. , in NHL, multiple myeloma, ovarian cancer). In some advanced disease settings, combinations of interferon alpha-2 with chemotherapeutic agents should now be investigated.

Key Features

Used Book in Good Condition

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
30 April 1985
Listed Since
12 January 2007

Barcode

No barcode data available

Similar Products You Might Like

Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)
99% match

Interferon Alpha-2: Pre-Clinical and Clinical Evaluation: Proceedings of the Symposium held in Adjunction with the Second International Conference on ... 13, 1984: 27 (Developments in Oncology, 27)

Springer

£77.81 08 Sep 2026
Interferon and Cancer
97% match

Interferon and Cancer

Springer

£74.69 30 Sep 2026
Interferon: The Science and Selling of a Miracle Drug (Routledge Studies in the History of Science, Technology and Medicine)
96% match

Interferon: The Science and Selling of a Miracle Drug (Routledge Studies in the History of Science, Technology and Medicine)

Routledge

£151.26 25 Aug 2026
Immune Interferon: Properties and Clinical Applications (Pharmacology and Toxicology: Basic and Clinical Aspects)
96% match

Immune Interferon: Properties and Clinical Applications (Pharmacology and Toxicology: Basic and Clinical Aspects)

CRC Press

£248.38 25 Aug 2026
Nova Science Interferons: Mechanism and Clinical Applications
96% match

Nova Science Interferons: Mechanism and Clinical Applications

Nova Science Publishers Inc

£150.14 03 Oct 2026
Anti-Infective Applications of Interferon-Gamma
95% match

Anti-Infective Applications of Interferon-Gamma

CRC Press

£164.06 23 Aug 2026
Viruses and Interferon: Current Research
95% match

Viruses and Interferon: Current Research

Caister Academic Press Limited

£199.00 24 Sep 2026
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
95% match

Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)

Elsevier

£73.99 23 Sep 2026
Bacterial Activation of Type I Interferons
95% match

Bacterial Activation of Type I Interferons

Springer

£75.08 30 Sep 2026
Novel Immunotherapeutic Approaches to Cancer Treatment - Springer
95% match

Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Springer

£108.91 03 Oct 2026
Novel Immunotherapeutic Approaches to Cancer Treatment - Springer
95% match

Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Springer

£114.88 02 Oct 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)
95% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)

Springer

£158.44 12 Sep 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
95% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Springer

£158.93 30 Sep 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
95% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£148.21 13 Oct 2026
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
95% match

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)

Humana

£92.38 11 Sep 2026
Type I Interferon in Autoimmune Diseases - Medical Book
95% match

Type I Interferon in Autoimmune Diseases - Medical Book

£72.27 05 Oct 2026
Infection and Cancer: Bi-Directorial Interactions
95% match

Infection and Cancer: Bi-Directorial Interactions

Springer

£109.24 23 Sep 2026
OSH Infection in the Immunocompromised Host (Oxford Specialist Handbooks)
94% match

OSH Infection in the Immunocompromised Host (Oxford Specialist Handbooks)

Oxford University Press

£59.43 18 Sep 2026
IL-1 in Cancer and Inflammation - Academic Press Medical Book
94% match

IL-1 in Cancer and Inflammation - Academic Press Medical Book

Elsevier

£125.39 02 Oct 2026
Prognostic and Therapeutic Applications of RKIP in Cancer
94% match

Prognostic and Therapeutic Applications of RKIP in Cancer

Elsevier

£101.86 24 Sep 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
94% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£69.37 22 Sep 2026
Modulation of Host Gene Expression and Innate Immunity by Viruses
94% match

Modulation of Host Gene Expression and Innate Immunity by Viruses

Springer

£110.33 08 Oct 2026
Negative Co-Receptors and Ligands: 350 (Current Topics in Microbiology and Immunology, 350)
94% match

Negative Co-Receptors and Ligands: 350 (Current Topics in Microbiology and Immunology, 350)

Springer

£96.82 24 Sep 2026
Burkitt Lymphoma: Updates in Etiology, Symptoms, Molecular Genetics and Treatment Options
94% match

Burkitt Lymphoma: Updates in Etiology, Symptoms, Molecular Genetics and Treatment Options

£192.99 18 Sep 2026